FDA Enforcement Class II Ongoing

Vanta/Seqenita LT Clinician Programmer Application, Neurostimulation systems for pain therapy, Model Number CT900C

Recall: Z-0913-2023 · Reported January 18, 2023

Enforcement

Recall Number
Z-0913-2023
Event ID
91296
Classification
Class II
Status
Ongoing
Product Type
Devices
Firm
Medtronic Neuromodulation
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Letter
Report Date
January 18, 2023
Initiation Date
December 3, 2022
Classification Date
January 6, 2023
Address
7000 Central Ave Ne, Minneapolis, MN, 55432-3568, United States

Description

Vanta/Seqenita LT Clinician Programmer Application, Neurostimulation systems for pain therapy, Model Number CT900C

Reason

Software anomalies, CP App messages: "Too Many Device Found", "Unexpected Device Error Code 1502", and "System Update Needed, Service Code 303"

Code Info

GTIN 00643169890961: Lot/Serial Numbers: NPL1000794, NPL1002295, NPL1002284, NPL1002272, NPL1001670, NPL1001615, NPL1001596, NPL1001588, NPL1001591, NPL1001592, NPL1001583, NPL1001579, NPL1001558, NPL1000777, NPL1000774, NPL1000776, NPL1000453, NPL1000429,

Distribution

Worldwide distribution.

Quantity

18 units